Tag Archive for: Astazeneca

RSV

Sanofi’s/Astazeneca’s anti-RSV antibody highly effective

NHS research partners of AstraZeneca and Sanofi have reported a 83% reduction in RSV infant hospitalisations in a post-approval clinical trial.

Read more